Precision BioSciences, Inc.

NASDAQ:DTIL

Biotechnology

Healthcare
$7.10 +1.69%

+$0.11 today

Market cap
$198.34M
Beta
1.28
P/E (TTM)
-1.9
EPS (TTM)
-$3.47
52W Low $3.53High $8.82

Volume 0.37M

Average 0.31M

DTIL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Precision BioSciences, Inc.NASDAQ: DTIL

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 12.83M shares rose 43.1% year over year, behind the +60.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +63.6% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +43.1% toward the trailing-twelve-month pace of +60.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
12.83M+0.0% QoQ
Last fiscal yearDec 2025
12.83M+86.3% YoY
LTMMar 2026
12.13M+60.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+43.1%——
1 year+86.3%——
3-year CAGR+63.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
12.83M USD
Year-over-year change
+86.3%
4-year CAGR
+60.0%

Weighted Avg Shares (Diluted) vs competitors

How DTIL compares with its peers on the latest reported figures

  • DTIL's LTM Mar 2026 weighted avg shares (diluted) of 12.13M shares is the lowest of the 7 companies compared; the peer median is 82.69M shares.
  • Its year-over-year change of +60.9% is the highest of 6, against a peer median of +5.6%.
  • Over three fiscal years its annual growth of +63.6% compares with a peer median of +15.2%.
DTIL Competitors Peer median
Weighted Avg Shares (Diluted) for DTIL and competitors
Company Period LTM YoY 3-year CAGR
GOSSGossamer Bio, Inc.LTM Mar 2026229M -0.3%+39.3%
HRTXHeron Therapeutics, Inc.LTM Mar 2026170.18M +11.3%+15.2%
ALECAlector, Inc.LTM Mar 2026104.14M +6.5%+7.7%
ABOSAcumen Pharmaceuticals, Inc.LTM Mar 202661.23M +1.8%+14.3%
RNAAtrium Therapeutics, Inc.FY202517.11M ——
QTTBQ32 Bio Inc.LTM Mar 202612.78M +5.6%+56.9%
DTILPrecision BioSciences, Inc.LTM Mar 202612.13M +60.9%+63.6%
Peer median (excluding DTIL) 82.69M+5.6%+15.2%

Competitors are the stored peer set for DTIL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue115.53M25.1M48.73M68.7M34.26M
Cost of Revenue00002.75M
Gross Profit115.53M25.1M48.73M68.7M31.51M
Gross Margin100.0%100.0%100.0%100.0%92.0%
Research & Development115.24M46.12M53.38M59.56M54.17M
Selling, General & Admin39.67M41.28M39.09M35.3M32.24M
Operating Expenses154.91M87.41M92.46M94.86M83.66M
Depreciation & Amortization10.2M9M8.26M4.58M2.75M
EBITDA(20.27M)(62.79M)(32.04M)13.53M(42.43M)
EBITDA Margin-17.5%-250.2%-65.8%19.7%-123.8%
Operating Income(39.38M)(62.31M)(43.74M)(26.16M)(52.15M)
Operating Margin-34.1%-248.3%-89.8%-38.1%-152.2%
Interest Income208K3.47M7.69M6.76M4.24M
Interest Expense132K1.11M2.23M1.78M1.42M
Other Income / Expenses8.77M(10.6M)1.21M33.33M5.54M
Income Before Tax(30.6M)(72.91M)(42.53M)7.17M(46.61M)
Pre-Tax Margin-26.5%-290.5%-87.3%10.4%-136.0%
Income Tax Expense00000
Net Income(30.6M)(111.64M)(61.32M)7.17M(46.61M)
Net Margin-26.5%-444.8%-125.8%10.4%-136.0%
EPS (Basic)(15.60)(38.10)(15.96)1.05(3.63)
EPS (Diluted)(15.60)(38.10)(15.96)1.04(3.63)
Weighted Avg Shares1.96M2.93M3.84M6.83M12.83M
Weighted Avg Shares (Diluted)1.96M2.93M3.84M6.88M12.83M

Precision BioSciences, Inc.

NASDAQ:DTIL

Intrinsic Alpha fair value

Locked

Current Price

$7.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.